Mayinglong Pharmaceutical Group Co., LTD. (600993.SS)

CNY 26.3

(0.88%)

Market Cap (In CNY)

11.33 Billion

Revenue (In CNY)

3.13 Billion

Net Income (In CNY)

443.25 Million

Avg. Volume

4.83 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
20.2-31.18
PE
-
EPS
-
Beta Value
0.579
ISIN
CNE000001HN2
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Youzhang Xia
Employee Count
-
Website
https://www.mayinglong.cn
Ipo Date
2004-05-17
Details
Mayinglong Pharmaceutical Group Co., LTD. engages in the manufacture, wholesale, and retail of pharmaceutical products primarily in China. It offers hemorrhoid, gynecological, cough, skin, functional food, and Chinese medicine drink tablet products, as well as medical devices. The company also sells its products online. It also operates hospitals. Mayinglong Pharmaceutical Group Co., LTD. was founded in 1582 and is based in Wuhan, China.